OMZO BY Scott Disick (US ONLY)

Let’s be real—weight management and the GLP-1 conversation have completely taken over the wellness and beauty space, shifting from whispered celebrity secrets to front-page news. Enter OMZO, the U.S.-based digital health and telehealth platform that has taken the industry by storm, particularly after appointing reality TV royalty Scott Disick as its high-profile partner and spokesperson in April 2026. After eagle-eyed fans spotted Mounjaro boxes in his fridge during an episode of The Kardashians, Disick didn't hide in the shadows; instead, he stepped into the light, proudly partnering with OMZO to normalize clinician-guided weight management and openly declaring his use of the platform.

OMZO isn't your traditional wellness brand peddling ineffective detox teas or questionable supplements. It is a cutting-edge, U.S.-based telehealth company dedicated to physician-led, personalized weight loss care. By offering streamlined access to game-changing GLP-1 medications like compounded semaglutide and tirzepatide, OMZO acts as the bridge between advanced pharmaceutical science and accessible, everyday wellness. The brand's ethos is rooted in transparency, safety, and eliminating the friction usually associated with specialized healthcare.

What makes the OMZO experience so unique is its holistic, destigmatized approach to metabolic health. They understand that medication is only one piece of the puzzle and that a quick fix isn't sustainable. Instead, OMZO couples its weekly injectables with rigorous clinical oversight, bespoke nutrition guidance, and continuous app-based support. They have essentially taken the concierge medicine experience and digitized it, allowing consumers to embark on a transformative health journey from the privacy of their own homes.

Because OMZO is a telehealth platform rather than a traditional consumer goods brand, its "hero products" are actually its comprehensive medical programs and prescription offerings. Here is what is flying off their digital shelves:

• OMZO Compounded Semaglutide Injection: The brand's entry-level hero, this once-weekly injectable program is beloved for mimicking the effects of GLP-1 naturally, helping to quiet food noise and support steady weight loss.
• OMZO Compounded Tirzepatide Injection: For those looking for a dual-action approach, this premium tier utilizes a combined GIP and GLP-1 receptor agonist (the same active ingredient found in Mounjaro) for maximum metabolic support.
• OMZO Personalized Weight-Loss Plan: The foundational product of the OMZO experience—a comprehensive, clinician-reviewed intake assessment that creates a roadmap tailored entirely to your unique biology.
• OMZO Ongoing Clinical Support: Consider this your digital concierge. This service provides continuous access to licensed medical providers for dosage adjustments and check-ins, ensuring you are never alone on your journey.
• OMZO Nutrition & Lifestyle Guidance: Because medicine works best with lifestyle changes, this program feature provides the dietary framework needed to maintain muscle mass and achieve sustainable health.
• OMZO Health Tracking App: The sleek digital companion that houses your entire program, allowing you to track progress, request refills, and message your care team with the tap of a screen.

• Founded / Prominence: Gained mainstream cultural prominence in 2026.
• Country of Origin: United States (Delaware-based).
• Key Figure: Partner & Spokesperson Scott Disick.
• Price Range: Monthly programs range from approximately $159 to $299+.
• Cruelty-Free / Vegan Status: Not applicable (as a medical platform, all prescription pharmaceutical treatments are subject to standard FDA clinical testing regulations).
• Where to Buy: Exclusively online at omzo.com.

OMZO is a comprehensive telehealth platform, not a drug manufacturer. They connect eligible patients with licensed U.S. clinicians who can prescribe compounded GLP-1 medications, which are then fulfilled by state-licensed partner pharmacies.

Through their licensed clinicians, OMZO primarily prescribes compounded semaglutide and compounded tirzepatide as weekly injectables, tailored to your specific metabolic needs.

No, OMZO operates on a straightforward self-pay, flat-pricing model. This means you do not need to fight with your insurance company for prior authorizations, though many patients successfully use FSA or HSA funds to cover the cost.

Pricing is highly competitive for the telehealth space, typically starting around $159 to $199 per month depending on the specific medication and plan. Importantly, OMZO offers flat-rate pricing, meaning your cost does not increase as your dosage increases.

Currently, OMZO is exclusively available within the United States. Due to strict telehealth and pharmaceutical regulations, the service operates only in the U.S. market.